Jul
29
2017
A team of Rockfeller scientists have described how SSRIs initiate their action by targeting a particular type of nerve cell, a finding which may herald a new type of fast-acting anti-depressants.
FOR GEOINFORMATICS AND SUSTAINABLE DEVELOPMENT
A team of Rockfeller scientists have described how SSRIs initiate their action by targeting a particular type of nerve cell, a finding which may herald a new type of fast-acting anti-depressants.